Verily’s Study Watch Rejected By FDA As Parkinson’s Drug-Development Tool
US regulators say Verily’s Study Watch – meant to be used in Parkinson’s trials – doesn’t collect data needed to assess whether a patient is truly benefitting from a drug.
You may also be interested in...
US FDA Clinical Outcome Assessments Studies Shed Light On Agency Thinking
The studies cover a broad range of devices and issues where information beyond traditional clinical trials data can be used to get a better picture of how a device affects patients.
Digital Health Roundup, May 2021: Immersive Technologies In Surgery Suite, ‘Smart’ Toilets And Pills; New SaMD Cybersecurity Standards
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from May.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.